Oppenheimer & Co’s Everus Construction Group ECG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.42M Buy
20,599
+7,165
+53% +$1.05M 0.04% 478
2026
Q1
$1.59M Sell
13,434
-413
-3% -$42.7K 0.02% 676
2025
Q4
$1.18M Sell
13,847
-2,093
-13% -$187K 0.02% 733
2025
Q3
$1.37M Sell
15,940
-2,472
-13% -$184K 0.02% 750
2025
Q2
$1.17M Sell
18,412
-4,828
-21% -$244K 0.02% 783
2025
Q1
$862K Buy
23,240
+13,757
+145% +$740K 0.01% 869
2024
Q4
$624K Buy
+9,483
New +$597K 0.01% 996

Other funds holding ECG

Oppenheimer & Co's ECG Position: Q2 2026 in Review

Oppenheimer & Co increased its Everus Construction Group (ECG) stake by 53% in Q2 2026, buying an estimated $1.05M and bringing the position to 20,599 shares worth $3.42M. The position accounts for 0.04% of the portfolio, ranked #478.

Oppenheimer & Co first reported a position in ECG in Q4 2024 and has held it in 7 quarters since. 539 funds tracked by Wall St. Rank hold ECG as of Q2 2026.

  • Oppenheimer & Co held 20,599 shares of Everus Construction Group worth $3.42M as of Q2 2026.
  • Oppenheimer & Co bought 7,165 Everus Construction Group shares in Q2 2026, an estimated $1.05M.
  • Everus Construction Group made up 0.04% of Oppenheimer & Co's portfolio in Q2 2026, its #478 holding.
  • Oppenheimer & Co first reported a position in Everus Construction Group in Q4 2024 and has held it in 7 quarters since.
  • 539 funds tracked by Wall St. Rank held Everus Construction Group as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.